Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jazz710
    Member
    • Oct 2012
    • 41

    #1

    Treatment of ChIP-Seq Input

    Hello all! I have placed this in the Bioinformatics forum because I believe this might be a more statistical problem, but if I'm incorrect, please don't hesitate to let me know.

    Briefly, I am doing a large (for me) ChIP-seq project. I have two species across three developmental stages. Each stage has condition 1 and condition 2, and there are replicates of each. Every sample had their IP and Input sequences to a minimum depth of 20M. (48 libraries: 24 Input, 24 IP).

    My question is about how to treat my inputs. Obviously, it would be ideal (I think) to normalize each IP against it's specific Input. That would be the most specific normalization.

    However, I can also imagine that by pooling the Inputs within a treatment (but not across replicates or species), I could compare each developmental stage within a treatment to a common Input with 3x greater depth.

    A single replicate example is below (there would be two replicated datasets like this)



    Any thoughts as two which would give the most robust results? I'm planning on running it both ways, but was hoping for some insight from someone with more experience in analyzing this type of data.

    Best and many thanks,
    Bob

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
68 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...